PQR-309

For research use only. Not for therapeutic Use.

  • CAT Number: I000865
  • CAS Number: 1225037-39-7
  • Molecular Formula: C₁₇H₂₀F₃N₇O₂
  • Molecular Weight: 411.39
  • Purity: ≥95%
Inquiry Now

PQR-309(Cat No.:I000865)is a dual inhibitor of PI3K and mTOR signaling pathways, both of which play critical roles in cell growth, survival, and metabolism. By targeting these pathways, PQR-309 effectively disrupts cancer cell proliferation and survival, making it a promising candidate for the treatment of various cancers, including solid tumors and hematologic malignancies. Its ability to inhibit both PI3K and mTOR provides a broader therapeutic effect compared to single-target inhibitors. PQR-309 is being investigated in clinical trials for its potential in oncology and combination therapies.


Catalog Number I000865
CAS Number 1225037-39-7
Molecular Formula C₁₇H₂₀F₃N₇O₂
Purity ≥95%
Target PI3K
Solubility 10 mM in DMSO
Storage -20°C
IUPAC Name 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
InChI InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)
InChIKey ADGGYDAFIHSYFI-UHFFFAOYSA-N
SMILES C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
Reference

<p style=/line-height:25px/>
<br>[1]. Cmiljanovic Vladimir, et al. Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes and their preparation. From PCT Int. Appl. (2010), WO 2010052569 A2 20100514.
</p>

Request a Quote